Critically important antimicrobials for human medicine
4th revison
Overview
The WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) reviews and updates the WHO list of critically important antimicrobials for human medicine in every two years. The current revision took place at the fifth meeting of the AGISAR held in Bogota, Colombia in 2013.
Related publications
-
Critically important antimicrobials for human medicine
3rd revision -
Critically important antimicrobials for human medicine
2nd revision -
Critically important antimicrobials for human medicine
1st revision - Critically important antibacterial agents for human medicine for risk management strategies of non-human use
- WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR)